Self-Adjuvanting Multicomponent Cancer Vaccine Candidates Combining Per-Glycosylated MUC1 Glycopeptides and the Toll-like Receptor 2 Agonist Pam3CysSer
Dr. Brendan L. Wilkinson, Dr. Stephanie Day, Lara R. Malins, Prof. Dr. Vasso Apostolopoulos, Dr. Richard J. PayneVolume:
123
Year:
2011
Language:
english
Pages:
5
DOI:
10.1002/ange.201006115
File:
PDF, 549 KB
english, 2011